We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-10.83%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$1.55B
AUM Growth
-$222M
Cap. Flow
-$13.5M
Cap. Flow %
-0.87%
Top 10 Hldgs %
17.52%
Holding
929
New
38
Increased
323
Reduced
374
Closed
111

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.49M
2
KO icon
Coca-Cola
KO
+$4.72M
3
ESRX
Express Scripts Holding Company
ESRX
+$2.71M
4
PX
Praxair Inc
PX
+$2.45M
5
XOM icon
ExxonMobil
XOM
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Financials 11.52%
3 Technology 11.46%
4 Consumer Staples 8.85%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
626
Boston Scientific
BSX
$68.4B
$253K 0.02%
7,170
+866
+14% +$31.4K
TRI icon
627
Thomson Reuters
TRI
$46.4B
$253K 0.02%
4,975
-1,442
-22% -$77.3K
MDP
628
DELISTED
Meredith Corporation
MDP
$253K 0.02%
4,876
-137
-3% -$7.43K
WP
629
DELISTED
Worldpay, Inc.
WP
$252K 0.02%
3,295
+566
+21% +$49.2K
PACW
630
DELISTED
PacWest Bancorp
PACW
$251K 0.02%
7,533
+609
+9% +$24.3K
FTV icon
631
Fortive
FTV
$18B
$250K 0.02%
5,867
+50
+0.9% +$2.35K
FLIR
632
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$250K 0.02%
5,761
-1,122
-16% -$55.2K
WAT icon
633
Waters Corp
WAT
$37.3B
$249K 0.02%
1,320
-40
-3% -$7.6K
DBJP icon
634
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$675M
$248K 0.02%
6,824
+124
+2% +$5.01K
TMX
635
DELISTED
Terminix Global Holdings, Inc.
TMX
$248K 0.02%
6,747
+972
+17% +$40.3K
FL
636
DELISTED
Foot Locker
FL
$247K 0.02%
+4,636
New +$233K
TY icon
637
TRI-Continental Corp
TY
$1.84B
$247K 0.02%
10,483
CDC icon
638
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$750M
$246K 0.02%
5,813
EFV icon
639
iShares MSCI EAFE Value ETF
EFV
$28.3B
$246K 0.02%
5,440
+1,459
+37% +$70.3K
GEM icon
640
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.6B
$246K 0.02%
8,159
-165
-2% -$5.05K
ICF icon
641
iShares Select U.S. REIT ETF
ICF
$2.13B
$246K 0.02%
5,150
-90
-2% -$4.49K
NDAQ icon
642
Nasdaq
NDAQ
$53.4B
$245K 0.02%
9,015
WEX icon
643
WEX
WEX
$6.42B
$245K 0.02%
1,744
+33
+2% +$5.43K
SIVB
644
DELISTED
SVB Financial Group
SIVB
$245K 0.02%
1,289
-568
-31% -$139K
BGR icon
645
BlackRock Energy and Resources Trust
BGR
$410M
$244K 0.02%
23,323
+2,753
+13% +$34.6K
IRDM icon
646
Iridium Communications
IRDM
$4.7B
$244K 0.02%
13,250
SNPS icon
647
Synopsys
SNPS
$71.6B
$244K 0.02%
2,894
-633
-18% -$56.2K
LYG icon
648
Lloyds Banking Group
LYG
$85.2B
$243K 0.02%
94,726
-62,140
-40% -$177K
AVY icon
649
Avery Dennison
AVY
$12.8B
$242K 0.02%
2,695
-517
-16% -$48.7K
CHD icon
650
Church & Dwight Co
CHD
$23.7B
$242K 0.02%
3,673
-3
-0.1% -$190

Similar funds

Raymond James Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James Trust held 929 positions worth $1.55B, down 12% from $1.78B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James Trust's Q4 2018 filing shows 38 new, 323 increased, 374 reduced and 111 closed positions. Its largest new stake was iShares MSCI ACWI ETF: 66,263 shares worth $4.25M. The largest sale was Merck, an estimated $5.49M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

  • Raymond James Trust's largest Q4 2018 buy was iShares MSCI ACWI ETF: 66,263 shares worth $4.25M.
  • Raymond James Trust added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $3.75M increase.
  • Raymond James Trust's biggest Q4 2018 reduction was Merck, cutting an estimated $5.49M.
  • Raymond James Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $2.71M.
  • Raymond James Trust's ten largest holdings make up 18% of its $1.55B portfolio in Q4 2018.
  • Raymond James Trust opened 38 new positions and closed 111 in Q4 2018.
  • Raymond James Trust's portfolio value fell 12% quarter-over-quarter to $1.55B.

Based on Raymond James Trust's 13F filing for Q4 2018, filed 29 Jan 2019.